Literature DB >> 32910923

Multidisciplinary Management of the Adverse Effects of Apremilast.

E Daudén Tello1, J Alonso Suárez2, E Beltrán Catalán3, C Blasco Maldonado4, M C Herrero Manso5, A Jiménez Morales6, I Marín-Jiménez7, M D Martín-Arranz8, A García-Merino9, J Porta Etessam10, M A Rodríguez-Sagrado11, J Rosas Gómez de Salazar12, E Trujillo Martín13, L Salgado-Boquete14.   

Abstract

We present a series of general and specific recommendations based on pathophysiologic considerations for managing the most common adverse effects of apremilast that lead to treatment discontinuation: diarrhea, nausea, and headache. The recommendations are based on a review of the literature and the experience of a multidisciplinary team of 14 experts including dermatologists, rheumatologists, neurologists, gastroenterologists, pharmacists, and nurses. We propose a series of simple algorithms that include clinical actions and suggestions for pharmacologic treatment. The adverse effects of apremilast can be managed from a multidisciplinary approach. The purpose of optimizing management is to bring clinical benefits to patients.
Copyright © 2020 AEDV. Publicado por Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Adverse effects; Apremilast; Cefalea; Diarrea; Diarrhea; Efectos adversos; Headache; Nausea; Náuseas; Psoriasis

Mesh:

Substances:

Year:  2020        PMID: 32910923     DOI: 10.1016/j.ad.2020.08.007

Source DB:  PubMed          Journal:  Actas Dermosifiliogr (Engl Ed)        ISSN: 2173-5778


  1 in total

1.  An Open-Label, Randomized, Prospective, Comparative, Three-Arm Clinical Trial to Evaluate the Safety and Effectiveness of Apremilast with Three Different Titration Methods in Patients with Chronic Plaque Psoriasis in India.

Authors:  Vishalakshi Viswanath; Pradnya Joshi; Prakash Lawate; Dakshata Tare; Dhiraj Dhoot; Namrata Mahadkar; Hanmant Barkate
Journal:  Psoriasis (Auckl)       Date:  2022-04-22
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.